Premature atherosclerosis in systemic sclerosis patients: Its relation to disease parameters and to traditional risk factors

International Journal of Rheumatic Diseases

Volumn 20, Issue 3, 2017, Pages 383-389

  Sedky Abdou, Manal M ^a   El Desouky, Soha M ^a   Helmy El Kaffas, Khaled M ^a   Ahmed Hassan, Abeer M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

arterial wall stiffness; atherosclerosis; systemic sclerosis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN; STEROID; TRIACYLGLYCEROL;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL PARAMETERS; BODY MASS; BRACHIAL ARTERY; CLINICAL ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; DOPPLER ULTRASONOGRAPHY; DRUG USE; DYSLIPIDEMIA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FLOW CHANGE; FLOW MEDIATED DILATATION; HUMAN; MALE; OBESITY; PEAK SYSTOLIC VELOCITY; PREMATURE ATHEROSCLEROSIS; PRIORITY JOURNAL; RISK FACTOR; SYSTEMIC SCLEROSIS; ADOLESCENT; BLOOD; BLOOD FLOW; CAROTID ARTERY; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC IMAGING; MIDDLE AGED; ONSET AGE; PATHOPHYSIOLOGY; VASODILATATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; RISK FACTORS; SCLERODERMA, SYSTEMIC; ULTRASONOGRAPHY, DOPPLER; VASODILATION; YOUNG ADULT;

EID: 85007494387     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/1756-185X.12987     Document Type: Article

References (38)

1. Hettema ME, Zhang D, de Leeuw K, Smit AJ, Kallenberg CGM, Bootsma H (2008) Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 10, R49.
2. Mayes MD, Lacey JV Jr, Deebe-Dimmer J et al. (2003) Prevalence, incidence, survival and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48, 2246–55.
3. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB et al. (2005) Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 118, 2–10.
4. Hadi HA, Carr CS, Suwaidi A (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1, 183–98.
5. Szodoray P, Timár O, Veres K et al. (2006) Th1/Th2 imbalance, measured by circulating and intracytoplasmic inflammatory cytokines-immunological alterations in acute coronary syndrome and stable coronary artery disease. Scand J Immunol 64, 336–44.
6. Matucci-Cerinic M, Fiori G, Grenbaum E, Schoenfeld Y (2003) Macrovascular disease in systemic sclerosis. In: Furst D, Clements P (eds) Systemic Sclerosis, pp 241. Lippincott Williams and Wilkins, Baltimore, MD.
7. Fatini C, Guiducci S, Abbate R, Matucci-Cerinic M (2004) Vascular injury in systemic sclerosis: angiotensin-converting enzyme insertion/depletion polymorphism. Curr Rheumatol Rep 6, 149–55.
8. Ross R (1999) Atherosclerosis-An inflammatory disease. N Engl J Med 340, 115–26.
9. Bartoli F, Blagojevic J, Bacci M et al. (2007) Flow-mediated vasodilatation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci 1108, 283–90.
10. Davis PH, Dawson JD, Riley WA et al. (2001) Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age. The muscatine study. Circulation 104, 2815–9.
11. Celemajer DS, Sorensen KE, Gooch VM et al. (1992) Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340, 1111–5.
12. Rollando D, Bezante GP, Sulli A et al. (2010) Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 37, 1168–73.
13. Doshi SN, Lewis MJ, Goodfellow J (2001) Improving endothelial vasomotor function. BMJ 323, 352–3.
14. Shoenfeld Y, Gerli R, Doria A et al. (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112, 3337–47.
15. Subcommitteee for Scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980). Arthritis Rheum 23, 581–90.
16. LeRoy EC, Black C, Fleischmajer R et al. (1988) Scleroderma (systemic sclerosis) classification, subsets and pathogenesis. J Rheumatol 15, 202–5.
17. Fernandes TM, Bica BEG, Villela NR et al. (2012) Evaluation of endothelial function in patients with limited systemic sclerosis by use of brachial artery Doppler ultrasound. Rev Bras Rheumatol 52, 554–68.
18. Clements PJ, Lachenbruch PA, Seibold JR et al. (1993) Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20, 1892–6.
19. Medsger TA, Bombardieri S, Czirjak L, Scorza R, Delia Rossa A, Bencivelli W (2003) Assessment of disease severity and prognosis. Clin Exp Rheumatol 21, S42–6.
20. York M, Farber HW (2011) Pulmonary hypertension: screening and evaluation in Scleroderma. Curr Opin Rheumatol 23, 536–44.
21. Tao JH, Wan YN, Zhang Y et al. (2015) Clinical and laboratory profiles of 136 systemic sclerosis patients with and without echocardiographically detected pulmonary hypertension. Z Rheumatol 74, 67–71.
22. Macy EM, Hayes TE, Tracy RP (1997) Variability in the measurement of C-reactive protein in healthy adults: implications for reference interval and epidemiologic methods. Clin Chem 43, 52–8.
23. Tam LS, Gladman DD, Hallett DC, Rahman P, Urowitz MB (2000) Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus. J Rheumatol 27, 2142–5.
24. Kahn CR, Rosenthal AS (1979) Immunologic reactions to insulin: insulin allergy, insulin resistance, and the autoimmune insulin syndrome. Diabetes Care 2, 283–95.
25. Szücs G, T'irmar O, Szekaneez Z et al. (2007) Endothelial dysfunction precedes atherosclerosis in systemic sclerosis- relevance for prevention of vascular complications. Rheumatology 46, 759–62.
26. D'Andrea A, Stisi S, Caso P et al. (2007) Associations between left ventricular myocardial involvement and endothelial dysfunction in systemic sclerosis: noninvasive assessment in asymptomatic patients. Echocardiography 24, 587–97.
27. Rossi P, Granel B, Marziale D, Le Mée F, Francès Y (2010) Endothelial function and hemodynamics in systemic sclerosis. Clin Physiol Funct Imaging 30, 453–9.
28. Lekakis J, Papamichael C, Mavrikakis M, Voutsas A, Stamatelopoulos S (1998) Effect of long-term estrogen therapy on brachial artery endothelium–dependent vasodilatation in women with Raynaud's phenomenon secondary to systemic sclerosis. Am J Cardiol 82, 1555–7, A8.
29. Cypiené A, Laucevicius A, Venalis A et al. (2008) The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 27, 1517–22.
30. Rajagopalan S, Pfenninger D, Kehrer C et al. (2003) Increased asymmetric dimethylarginine and endothelin 1 levels in secondary Raynaud's phenomenon: implications for vascular dysfunction and progression of disease. Arthritis Rheum 48, 1992–2000.
31. Roustit M, Simmons GH, Baguet JP, Carpentier P, Cracowski JL (2008) Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 35, 1576–83.
32. Stucker M, Quinna S, Memmel U et al. (2000) Macroangiopathy of the upper extremeties in progressive systemic sclerosis. Eur J Med Res 19, 295–302.
33. Anderson GN, Mincheva-Nilsson L, Kazzam E et al. (2002) Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production. Arthritis Rheum 46, 1324–32.
34. Soltész P, Dér H, Kerekes G et al. (2009) A comparative study of arterial stiffness, flow-mediated vasodilatation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases. Clin Rheumatol 28, 655–62.
35. Cheng KS, Tiwari A, Boutin A et al. (2003) Differentiation of primary and secondary Raynaud's disease by carotid arterial stiffness. Eur J Vasc Endovasc Surg 25, 336–41.
36. Cheng KS, Tiwari A, Boutin A (2003) Carotid and femoral arterial wall mechanics in scleroderma. Rheumatology (Oxford) 42, 1299–305.
37. Kaloudi O, Basta G, Perfetto F et al. (2007) Circulating levels of Nepsilon-(carboxymethyl) lysine are increased in systemic sclerosis. Rheumatology (Oxford) 46, 412–6.
38. Alexandrov AV, Brodie DS, Mclean A, Hamilton P, Murphy J, Burns PN (1997) Correlation of peak systolic velocity and angiographic measurement of carotid stenosis revisited. Stroke 28, 339–42.